Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,125.00
+42.00 (2.02%)
Sep 21, 2026, 3:15 PM IST
Lupin Employees
Lupin had 26,021 employees as of March 31, 2026. The number of employees increased by 2,015 or 8.39% compared to the previous year.
Employees
26,021
Change (1Y)
2,015
Growth (1Y)
8.39%
Revenue / Employee
11.52M INR
Profits / Employee
2.12M INR
Market Cap
969.34B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 26,021 | 2,015 | 8.39% |
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 31,369 |
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 16,946 |
| Divi's Laboratories | 11,565 |
Lupin News
- 17 days ago - Lupin Gets FDA Approval For Modafinil Tablets - Nasdaq
- 4 weeks ago - Lupin And Tenpoint Partner To Expand YUVEZZI In Europe - Nasdaq
- 4 weeks ago - Lupin Secures FDA Approval For Pitolisant Tablets, Generic Of WAKIX; Expects Launch In 2030 - Nasdaq
- 6 weeks ago - Lupin Transcript: Q1 26/27 - Transcripts
- 6 weeks ago - Lupin Quarterly report: Q1 2027 - Filings
- 6 weeks ago - Lupin Slides: Q1 2027 - Filings
- 2 months ago - Lupin Transfers Two Oncology Assets To Kaveri Therapeutics - Nasdaq
- 2 months ago - Lupin receives EIR from U.S. FDA for Somerset facility with VAI classification - Business Upturn